Automate Your Wheel Strategy on PTIXW
With Tiblio's Option Bot, you can configure your own wheel strategy including PTIXW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PTIXW
- Rev/Share 0.0
- Book/Share -0.1688
- PB -22.8132
- Debt/Equity 0.0
- CurrentRatio 0.8618
- ROIC 61.2542
- MktCap 3343394.0
- FreeCF/Share -6.9266
- PFCF -0.9222
- PE -0.3845
- Debt/Assets 0.0
- DivYield 0
- ROE -8.6052
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
About Protagenic Therapeutics, Inc. (PTIXW)
- IPO Date 2021-04-27
- Website http://www.protagenic.com
- Industry Biotechnology
- CEO Dr. Garo H. Armen Ph.D.
- Employees 1
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.